SCHEMBL8646446

SCHEMBL8646446

CC(=O)NCc1cccc(C(C)=O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 2/20 0.57
▸ HDAC6 Q9UBN7 2/20 0.57
▸ HDAC3 O15379 1/20 0.57
▸ HDAC4 P56524 1/20 0.57
▸ HDAC7 Q8WUI4 1/20 0.57
▸ HDAC2 Q92769 1/20 0.57
▸ HDAC10 Q969S8 1/20 0.57
▸ HDAC11 Q96DB2 1/20 0.57
▸ HDAC8 Q9BY41 1/20 0.57
▸ HDAC9 Q9UKV0 1/20 0.57
▸ HDAC5 Q9UQL6 1/20 0.57
▸ KMT2A Q03164 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ NR1H4 Q96RI1 1/20 0.49
▸ CYP19A1 P11511 1/20 0.49
▸ MMP13 P45452 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ LIPG Q9Y5X9 1/20 0.48
▸ MAOB P27338 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3530258 0.88 KMT2A (0.64) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL18095346 0.88 TSHR (0.54) HDAC6HDAC2HDAC8KMT2ATSHR
SCHEMBL1899410 0.87 NPSR1 (0.57) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL2828029 0.86 F10 (0.57) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL19634801 0.85 SLC7A5 (0.58) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL19634740 0.85 LOXL2 (0.64) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL4623980 0.85 TSHR (0.55) TSHRNR1H4CYP19A1MMP13MAOB
SCHEMBL10131961 0.84 NOS1 (0.51) KMT2ATSHRCYP19A1MAOBALDH1A1
SCHEMBL25779414 0.83 TSHR (0.47) KMT2ATSHRNR1H4CYP19A1MMP13
SCHEMBL8647807 0.83 HDAC1 (0.59) HDAC1HDAC6HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0545376-B1 Guanidino thiazoles and their use as H2-receptor antagonist FUJISAWA PHARMACEUTICAL CO (JP) 1998-09-09 — — EP disclosed
EP-0784612-A1 UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-07-23 — — EP disclosed
US-5532258-A ANTIULCER AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 — — US disclosed
WO-1996010559-A1 UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-04-11 — — WO disclosed
WO-1996005187-A1 (4-(3-AMINOMETHYLPHENYL)THIAZOL-2-YL)-GUANIDINES AS H2-RECEPTOR ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-02-22 — — WO disclosed
CN-1089259-A New compound FUJISAWA PHARMACEUTICAL CO (JP) 1994-07-13 — — CN disclosed
CN-1079469-A Preparation method with thiazole derivative of antiulcer activity and Histamine Receptors antagonistic action FUJISAWA PHARMACEUTICAL CO (JP) 1993-12-15 — — CN disclosed
EP-0545376-A1 Guanidino thiazoles and their use as H2-receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-06-09 — — EP disclosed
Send feedback